# Autism Spectrum Disorder: Classification, diagnosis and therapy
> [!info]+ <center>Metadata</center>
> 
> |<div style="width: 5em">Key</div>|Value|
> |--:|:--|
> |文献类型|journalArticle|
> |标题|Autism Spectrum Disorder: Classification, diagnosis and therapy|
> |短标题|自闭症谱系障碍：分类、诊断和治疗|
> |作者|Samata R. Sharma、 Xenia Gonda、 Frank I. Tarazi|
> |期刊名称|[[Pharmacology & Therapeutics]]|
> |DOI|[10.1016/j.pharmthera.2018.05.007](https://doi.org/10.1016/j.pharmthera.2018.05.007)|
> |存档位置||
> |馆藏目录|13.5 (Q1)|
> |索书号|1|
> |版权|4⭐|
> |分类|[[ASD]]|
> |条目链接|[My Library](zotero://select/library/items/7HMDA9EW)|
> |PDF 附件|[全文](zotero://open-pdf/library/items/RUX7HAA9)|
> |关联文献||
> ^Metadata

> [!example]- <center>本文标签</center>
> 
> `$=dv.current().file.tags`

> [!quote]- <center>Abstract</center>
> 
> Autism Spectrum Disorder (ASD) refers to a group of neurodevelopmental disorders including autism, Asperger's syndrome (AS) and pervasive developmental disorder-not otherwise specified (PDD-NOS). The new diagnostic criteria of ASD focuses on two core domains: social communication impairment and restricted interests/repetitive behaviors. The prevalence of ASD has been steadily increasing over the past two decades, with current estimates reaching up to 1 in 36 children. Hereditary factors, parental history of psychiatric disorders, pre-term births, and fetal exposure to psychotropic drugs or insecticides have all been linked to higher risk of ASD. Several scales such as the Childhood Autism Rating Scale (CARS), The Autism Spectrum Disorder–Observation for Children (ASD-OC), The Developmental, Dimensional, and Diagnostic Interview (3di), are available to aid in better assessing the behaviors and symptoms associated with ASD. Nearly 75% of ASD patients suffer from comorbid psychiatric illnesses or conditions, which may include attention-deficit hyperactivity disorder (ADHD), anxiety, bipolar disorder, depression, Tourette syndrome, and others. Both pharmacological and non-pharmacological interventions are available for ASD. Pharmacological treatments include psychostimulants, atypical antipsychotics, antidepressants, and alpha-2 adrenergic receptor agonists. These medications provide partial symptomatic relief of core symptoms of ASD or manage the symptoms of comorbid conditions. Non-pharmacological interventions, which show promising evidence in improving social interaction and verbal communication of ASD patients, include music therapy, cognitive behavioral therapy and social behavioral therapy. Hormonal therapies with oxytocyin or vasopressin receptor antagonists have also shown some promise in improving core ASD symptoms. The use of vitamins, herbal remedies and nutritional supplements in conjunction with pharmacological and behavioral treatment appear to have some effect in symptomatic improvement in ASD, though additional studies are needed to confirm these benefits. Developing novel disease-modifying therapies may prove to be the ultimate intervention for sustained improvement of symptoms in ASD.
>
>【摘要翻译】自闭症谱系障碍（ASD）是指一组神经发育障碍，包括自闭症、阿斯伯格综合症（AS）和广泛性发育障碍——未另有说明（PDD-NOS）。ASD的新诊断标准侧重于两个核心领域：社会交流障碍和受限兴趣/重复行为。在过去的二十年里，ASD的患病率一直在稳步上升，目前的估计高达36名儿童中的1名。遗传因素、父母精神障碍史、早产和胎儿接触精神药物或杀虫剂都与ASD的高风险有关。儿童自闭症分级量表（CARS）、儿童自闭症谱系障碍观察（ASD-OC）、发育、维度和诊断访谈（3di）等几个量表可用于帮助更好地评估与ASD相关的行为和症状。近75%的ASD患者患有共病精神疾病或病症，其中可能包括注意力缺陷多动障碍（ADHD）、焦虑、双相情感障碍、抑郁症、抽动症等。药物和非药物干预均可用于ASD。药物治疗包括精神刺激剂、非典型抗精神病药物、抗抑郁药和α-2肾上腺素能受体激动剂。这些药物可部分缓解ASD的核心症状或控制共病症状。非药物干预在改善ASD患者的社会互动和语言交流方面显示出有希望的证据，包括音乐疗法、认知行为疗法和社会行为疗法。含催产素或加压素受体拮抗剂的激素疗法也显示出改善ASD核心症状的一些希望。维生素、草药和营养补充剂与药物和行为治疗相结合的使用似乎对ASD的症状改善有一定的效果，尽管需要更多的研究来证实这些益处。开发新的疾病调节疗法可能被证明是持续改善ASD症状的最终干预措施。

> [!tldr]- <center>隐藏信息</center>
> 
> itemType:: journalArticle
> title:: Autism Spectrum Disorder: Classification, diagnosis and therapy
> shortTitle:: 自闭症谱系障碍：分类、诊断和治疗
> creators:: Samata R. Sharma、 Xenia Gonda、 Frank I. Tarazi
> publicationTitle:: [[Pharmacology & Therapeutics]]
> journalAbbreviation:: Pharmacol. Ther.
> volume:: 190
> issue:: 
> pages:: 91-104
> language:: en
> DOI:: [10.1016/j.pharmthera.2018.05.007](https://doi.org/10.1016/j.pharmthera.2018.05.007)
> ISSN:: 0163-7258
> url:: [https://linkinghub.elsevier.com/retrieve/pii/S0163725818300871](https://linkinghub.elsevier.com/retrieve/pii/S0163725818300871)
> archive:: 
> archiveLocation:: 
> libraryCatalog:: 13.5 (Q1)
> callNumber:: 1
> rights:: 4⭐
> extra:: 
> collection:: [[ASD]]
> tags:: #Done
> related:: 
> itemLink:: [My Library](zotero://select/library/items/7HMDA9EW)
> pdfLink:: [全文](zotero://open-pdf/library/items/RUX7HAA9)
> qnkey:: 2018_Sharma_Autism Spe_KEY-7HMDA9EW
> date:: 2018-10
> dateY:: 2018
> dateAdded:: 2024-02-26
> dateModified:: 2024-03-04
> 
> abstract:: Autism Spectrum Disorder (ASD) refers to a group of neurodevelopmental disorders including autism, Asperger's syndrome (AS) and pervasive developmental disorder-not otherwise specified (PDD-NOS). The new diagnostic criteria of ASD focuses on two core domains：social communication impairment and restricted interests/repetitive behaviors. The prevalence of ASD has been steadily increasing over the past two decades, with current estimates reaching up to 1 in 36 children. Hereditary factors, parental history of psychiatric disorders, pre-term births, and fetal exposure to psychotropic drugs or insecticides have all been linked to higher risk of ASD. Several scales such as the Childhood Autism Rating Scale (CARS), The Autism Spectrum Disorder–Observation for Children (ASD-OC), The Developmental, Dimensional, and Diagnostic Interview (3di), are available to aid in better assessing the behaviors and symptoms associated with ASD. Nearly 75% of ASD patients suffer from comorbid psychiatric illnesses or conditions, which may include attention-deficit hyperactivity disorder (ADHD), anxiety, bipolar disorder, depression, Tourette syndrome, and others. Both pharmacological and non-pharmacological interventions are available for ASD. Pharmacological treatments include psychostimulants, atypical antipsychotics, antidepressants, and alpha-2 adrenergic receptor agonists. These medications provide partial symptomatic relief of core symptoms of ASD or manage the symptoms of comorbid conditions. Non-pharmacological interventions, which show promising evidence in improving social interaction and verbal communication of ASD patients, include music therapy, cognitive behavioral therapy and social behavioral therapy. Hormonal therapies with oxytocyin or vasopressin receptor antagonists have also shown some promise in improving core ASD symptoms. The use of vitamins, herbal remedies and nutritional supplements in conjunction with pharmacological and behavioral treatment appear to have some effect in symptomatic improvement in ASD, though additional studies are needed to confirm these benefits. Developing novel disease-modifying therapies may prove to be the ultimate intervention for sustained improvement of symptoms in ASD.【摘要翻译】自闭症谱系障碍（ASD）是指一组神经发育障碍，包括自闭症、阿斯伯格综合症（AS）和广泛性发育障碍——未另有说明（PDD-NOS）。ASD的新诊断标准侧重于两个核心领域：社会交流障碍和受限兴趣/重复行为。在过去的二十年里，ASD的患病率一直在稳步上升，目前的估计高达36名儿童中的1名。遗传因素、父母精神障碍史、早产和胎儿接触精神药物或杀虫剂都与ASD的高风险有关。儿童自闭症分级量表（CARS）、儿童自闭症谱系障碍观察（ASD-OC）、发育、维度和诊断访谈（3di）等几个量表可用于帮助更好地评估与ASD相关的行为和症状。近75%的ASD患者患有共病精神疾病或病症，其中可能包括注意力缺陷多动障碍（ADHD）、焦虑、双相情感障碍、抑郁症、抽动症等。药物和非药物干预均可用于ASD。药物治疗包括精神刺激剂、非典型抗精神病药物、抗抑郁药和α-2肾上腺素能受体激动剂。这些药物可部分缓解ASD的核心症状或控制共病症状。非药物干预在改善ASD患者的社会互动和语言交流方面显示出有希望的证据，包括音乐疗法、认知行为疗法和社会行为疗法。含催产素或加压素受体拮抗剂的激素疗法也显示出改善ASD核心症状的一些希望。维生素、草药和营养补充剂与药物和行为治疗相结合的使用似乎对ASD的症状改善有一定的效果，尽管需要更多的研究来证实这些益处。开发新的疾病调节疗法可能被证明是持续改善ASD症状的最终干预措施。


👣➿👣

## ✏️ 笔记区

> [!WARNING]+ <center>🐣 总结</center>  
>
>🎯 研究问题::  
>🔎 研究背景::  
>🚀 研究方法::  
>🐔 研究思路::  
>📺 主要内容::  详细介绍了孤独症谱系障碍的发展，现状，病因，诊断、治疗以及共病疾病
>🎉 研究结论::  
>🗝️ 创新点::  
>💩 研究局限::  
>🐾 研究展望::  
>✏️ 备注::  

> [!inbox]- <center>📫 导入时间</center>
>
> ⏰ importDate:: 2024-02-29

👣➿👣

## 📝 注释笔记 RUX7HAA9

> <span style="font-size: 15px;color: gray">📍 2018-Sharma-Autism Spectrum Disorder: Classification, diagnosis and therapy</span>

^KEYrefTitle

> <span class="highlight" style="background-color: #ffd40020">The new diagnostic criteria of ASD focuses on two core domains: social communication impairment and restricted interests/repetitive behaviors.</span>
> 
> DSM-5：新的 ASD 诊断标准侧重于两个核心领域：社会沟通障碍和兴趣受限/重复行为。【👈 译】 ([p3](zotero://open-pdf/library/items/RUX7HAA9?page=3&annotation=YRQIZ8JH))

^KEYYRQIZ8JH

> <span class="highlight" style="background-color: #ffd40020">Children diagnosed with these disorders typically showed deficits in three domains: social interaction, communication, and repetitive/restricted behaviors.</span>
> 
> DSM-4：被诊断出患有这些障碍的儿童通常在三个方面表现出缺陷：社会交往、沟通和重复/受限行为。【👈 译】 ([p7](zotero://open-pdf/library/items/RUX7HAA9?page=7&annotation=3SUA4SEK))

^KEY3SUA4SEK

> <span class="highlight" style="background-color: #ff666620">Diagnosis of ASD</span>
> 
> ASD 诊断：多种方法【👈 译】 ([p13](zotero://open-pdf/library/items/RUX7HAA9?page=13&annotation=3FREVQFY))
> 
> 🏷️ #📝/孤独症诊断

^KEY3FREVQFY

